World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
46
Citations
8208
World Ranking
15996
National Ranking
593

Romano Silvestri publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Romano Silvestri sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 266 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Romano Silvestri D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Romano Silvestri sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 46 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Romano Silvestri is affiliated with Sapienza University of Rome in Italy. Their research spans several fields within the biomedical sciences, notably biochemistry, genetics, and molecular biology, with a significant focus on medicine. Their work notably covers subfields such as molecular biology, organic chemistry, oncology, infectious diseases, and cell biology.

Their contributions to science include research on various topics, such as cancer-related gene regulation, synthesis and biological activity of compounds, Wnt/β-catenin signaling in development and cancer, viral gastroenteritis research and epidemiology, viral infections and immunology, cancer therapeutics and mechanisms, and computational drug discovery methods.

Romano Silvestri has published multiple papers in well-regarded journals and scientific venues. Some recent notable publications include:

  • Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection, 2023, Circulation Research
  • Modulating undruggable targets to overcome cancer therapy resistance, 2021, Drug Resistance Updates
  • Emerging Therapeutic Agents for Colorectal Cancer, 2021, Molecules
  • Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer, 2021, Biology Direct
  • Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia, 2021, European Journal of Medicinal Chemistry

Their frequent coauthors include Giuseppe La Regina, Antonio Coluccia, Michela Puxeddu, Marianna Nalli, and Domiziana Masci. Collaboration with these researchers has contributed to a range of studies reflecting interdisciplinary approaches across chemistry, biology, pharmacology, and oncology.

Romano Silvestri's work has appeared predominantly in several scientific journals, emphasizing the following venues:

  • Molecules
  • European Journal of Medicinal Chemistry
  • Journal of Medicinal Chemistry
  • SSRN Electronic Journal
  • European Journal of Pharmacology

Throughout their career, Romano Silvestri has maintained an extensive publication record with an emphasis on translational research that integrates molecular mechanisms and therapeutic development.

Best Publications

  • New Arylthioindoles: Potent Inhibitors of Tubulin Polymerization. 2. Structure−Activity Relationships and Molecular Modeling Studies

    Gabriella De Martino;Michael C. Edler;Giuseppe La Regina;Antonio Coluccia

  • Indole, a core nucleus for potent inhibitors of tubulin polymerization.

    Andrea Brancale;Romano Silvestri

  • Arylthioindoles, Potent Inhibitors of Tubulin Polymerization

    Gabriella De Martino;Giuseppe La Regina;Antonio Coluccia;Michael C. Edler

  • New Frontiers in Selective Human MAO-B Inhibitors

    Simone Carradori;Romano Silvestri

  • Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies

    Giuseppe La Regina;Michael C. Edler;Andrea Brancale;Sahar Kandil

  • Novel Indolyl Aryl Sulfones Active against HIV-1 Carrying NNRTI Resistance Mutations: Synthesis and SAR Studies

    Romano Silvestri;Gabriella De Martino;Giuseppe La Regina;Marino Artico

  • Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.

    Rino Ragno;Antonio Coluccia;Giuseppe La Regina;Gabriella De Martino

  • Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease

    Romano Silvestri

  • Indolylarylsulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: New Cyclic Substituents at Indole-2-carboxamide

    Giuseppe La Regina;Antonio Coluccia;Andrea Brancale;Francesco Piscitelli

  • 2-Sulfonyl-4-chloroanilino Moiety: A Potent Pharmacophore for the Anti-Human Immunodeficiency Virus Type 1 Activity of Pyrrolyl Aryl Sulfones

    Artico M;Silvestri R;Massa S;Loi Ag

  • Structure-based design, synthesis, and biological evaluation of novel pyrrolyl aryl sulfones: HIV-1 non-nucleoside reverse transcriptase inhibitors active at nanomolar concentrations.

    Marino Artico;Romano Silvestri;Eugenia Pagnozzi;Biancamaria Bruno

  • The tubulin colchicine domain: a molecular modeling perspective.

    Alberto Massarotti;Antonio Coluccia;Romano Silvestri;Giovanni Sorba

  • Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors

    Giuseppe La Regina;Ruoli Bai;Whilelmina Maria Rensen;Erica Di Cesare

  • New Pyrrole Inhibitors of Monoamine Oxidase: Synthesis, Biological Evaluation, and Structural Determinants of MAO-A and MAO-B Selectivity

    Giuseppe La Regina;Romano Silvestri;Marino Artico;Antonio Lavecchia

  • Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus

    Marcella Bassetto;Tine De Burghgraeve;Leen Delang;Alberto Massarotti

  • Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects.

    Roberto Carnevale;Romano Silvestri;Lorenzo Loffredo;Marta Novo

  • New Arylthioindoles and Related Bioisosteres at the Sulfur Bridging Group. 4. Synthesis, Tubulin Polymerization, Cell Growth Inhibition, and Molecular Modeling Studies

    Giuseppe La Regina;Taradas Sarkar;Ruoli Bai;Michael C. Edler

  • Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives.

    Rino Ragno;Marino Artico;Gabriella De Martino;Giuseppe La Regina

  • Synthesis, biological evaluation, and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptase.

    Romano Silvestri;Marino Artico;Gabriella De Martino;Rino Ragno

  • New Pyrrole Derivatives with Potent Tubulin Polymerization Inhibiting Activity As Anticancer Agents Including Hedgehog-Dependent Cancer

    Giuseppe La Regina;Ruoli Bai;Antonio Coluccia;Valeria Famiglini

Frequent Co-Authors

Marino Artico
Marino Artico Sapienza University of Rome
Ettore Novellino
Ettore Novellino University of Naples Federico II
Giovanni Maga
Giovanni Maga National Research Council (CNR)
Ernest Hamel
Ernest Hamel National Institutes of Health
Antonio Lavecchia
Antonio Lavecchia University of Naples Federico II
Paolo La Colla
Paolo La Colla University of Cagliari
Johan Neyts
Johan Neyts Rega Institute for Medical Research
Claudia Martini
Claudia Martini University of Pisa
Patrizia Lavia
Patrizia Lavia Sapienza University of Rome
Antonello Mai
Antonello Mai Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying chemistry in the USA opens doors to various related fields and career opportunities. For those interested in legal aspects connected to chemistry, exploring criminal justice associate programs online can provide foundational knowledge of the justice system, which intersects with forensic chemistry.

Alternatively, careers such as a paralegal play a significant role in supporting legal professionals, especially in patent law or regulatory compliance. Students can investigate different paralegal degree options to find a path that fits their interests and goals.

For those looking to enter the pharmaceutical industry, becoming a pharmaceutical sales representative is a popular route. Understanding the pharmaceutical sales salary and career paths helps in evaluating this profession’s potential for growth and financial reward.

Finally, pursuing advanced education is essential to become a pharmacist. Knowing the pharmacist education requirements can guide chemistry students in preparing for this highly respected and in-demand healthcare career.

Best Scientists Citing Romano Silvestri

Trending Scientists

Recently Published Articles